Who
Faraz Ali
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Tenaya Therapeutics; Chief Business Officer, Regenxbio.
In numbers
- Trades disclosed
- 51
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $172K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Mar 2016
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —122,000 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —732,500 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —732,500 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —122,000 at $0.00 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,1435,837 at $0.7097 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,8173,969 at $0.7098 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,5635,020 at $0.7097 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,2567,406 at $0.7097 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,1445,837 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,8183,969 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,5645,020 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,2587,406 at $0.71 | filing |
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,6903,390 at $0.7934 | filing |
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,6783,390 at $0.79 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,7625,851 at $0.643 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,5593,979 at $0.6431 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,2365,032 at $0.643 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,7455,851 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,5473,979 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,2205,032 at $0.64 | filing |
News
Tenaya Therapeutics (NASDAQ:TNYA) versus Sutro Biopharma (NASDAQ:STRO) Head-To-Head ComparisonTNYA · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Faraz Ali; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.